FDA Names Top HHS Lawyer as Chief Counsel
FDA Names Top HHS Lawyer as Chief Counsel
http://www.fda.gov/news-events/press-announcements/fda-names-top-hhs-lawyer-chief-counsel
FDA is Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use: Drug Safety Communication
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
http://www.fda.gov/news-events/press-announcements/fda-requires-major-changes-opioid-pain-medication-labeling-emphasize-risks
PAHO’s Virtual Campus for Public Health surpasses 4 million users
Cristina Mitchell
30 Jul 2025
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
FDA Takes Steps to Restrict 7-OH Opioid Products Threatening American Consumers
http://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
PAHO Director warns of intensifying climate threats to health in the Americas at global conference in Brazil
Cristina Mitchell
29 Jul 2025
Brazil and PAHO host strategic meeting to strengthen regional supply of medicines, vaccines, and health technologies
Cristina Mitchell
29 Jul 2025
PAHO/WHO convenes journalists to reshape how road safety is covered in Latin America
Cristina Mitchell
28 Jul 2025
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
FDA Recommends Removal of Voluntary Hold for Elevidys for Ambulatory Patients
http://www.fda.gov/news-events/press-announcements/fda-recommends-removal-voluntary-hold-elevidys-ambulatory-patients